March 08, 2022 02:39 ET | Source: Vantage Market Research Vantage Market Research
WASHINGTON, March 08, 2022 (GLOBE NEWSWIRE) — Vantage Market Research’s recent analysis of the Global Brain Pacemaker Market finds that high treatment and diagnosis rate of diseases such as, Parkinson’s disease, epilepsy & other neuro-stimulation diseases is a key factor that propel the growth of Brain Pacemaker Market in coming years. However, high device cost and stringent regulations for medical devices are some of the key obstacles that hamper the growth of Brain Pacemaker Market during forecast period. Whereas, increasing research trials and emergence of technically sound medical equipment will provide lucrative growth opportunities for Brain Pacemaker Market in near future. The total Global Brain Pacemaker Market is estimated to reach USD 3.941 Billion by 2028.
The market stood at a revenue of USD 1.44 Billion in the year 2021, and expected to grow at a Compound Annual Growth Rate (CAGR) of 15.1%, states Vantage Market Research, in a report, titled “Brain Pacemaker Market by Application (Parkinson’s Disease, Essential Tremor, Obsessive-Compulsive Disorder, Epilepsy), by End-User (Hospitals, Ambulatory Surgical Centers & Clinics, Others), by Region (North America, Europe, Asia Pacific, Latin America) – Global Industry Assessment (2016 – 2021) & Forecast (2022 – 2028)”.
Please Check Out Our Free Sample Reports and Make a More Informed Decision:
Get Access to a Free Copy of Our Latest Sample Report @ https://www.vantagemarketresearch.com/brain-pacemaker-market-1312/request-sample
(Sample reports are a great way to test our in-depth reports or study before you make a purchase)
High Usage of Brain Pacemaker in Neurological Disorders Propels the Market
Nowadays, neurological disorders such as, Parkinson, Epilepsy and Alzheimer are increasing at a pace. A Brain Pacemaker is an electronic device that provides electrical pulse to specific targets in the brain. This device is majorly used in neurological disorders to regulate the stimulation parameters in real-time. Thus, increasing incidences of neurological disorders is expected to augment the growth of Brain Pacemaker Market in recent years. In addition, this device provides potential benefits such as, better management of postoperative outcomes, resist the irregular electrical movements of the brain, long-term efficacy and deliver electrical signal & record electrical activities of the brain. All these benefits are also responsible for augmenting the growth of Brain Pacemaker Market in coming years.
Technological Advancement in Brain Pacemaker Augment the Market Demand
Many researchers & physicians are started clinical studies to offer an advanced system to medical team and it requires huge investment for doing these research activities. In addition, various advanced technology is introduced in Brain Pacemaker devices that includes, magnetic resonance imaging (MRI), robot-assisted implantation, integrated implantable pulse generators, enhanced microelectrode designs, individualized directed programming and multi-target stimulation. This advancement of Brain Pacemaker device introduces various features such as, greater efficacy, lesser adverse effects and symptomatic relief in patients. Thus, advancement in technologically sound Brain Pacemaker devices is accelerating the high growth of Brain Pacemaker Market in recent years.
Purchase This Premium Report Now @ https://www.vantagemarketresearch.com/buy-now/brain-pacemaker-market-1312/0
Benefits of Purchasing Brain Pacemaker Market Reports:
COVID-19 Impact Analysis:
The COVID-19 outbreak has affected various industries worldwide. Governments across the world implemented strict lockdown measures and social distancing norms in order to restrict the swift spread of the pandemic. Manufacturing facilities around the world were shut down during the initial stages of the pandemic. Moreover, the economic crisis after the pandemic might lead to a significant delay in the commercial roll-out of the electronics industry. Small and medium-scale companies are the backbone of technology providers and are witnessing a steep drop in revenue since the emergence of the pandemic in 2020. Hence, market players faced numerous challenges as disruptions in the supply chain were observed. However, things will improve in the second half of 2022 as more supplies will come online. The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends of the market for all the regions and countries based on the following data points:
Read Full Research Report @ https://www.vantagemarketresearch.com/industry-report/brain-pacemaker-market-1312
The Report on Brain Pacemaker Market Highlights:
North America Accounted Largest Growth of Market
North America is predicted to witness high growth of Brain Pacemaker Market during forecast period. This growth is accounted owing to the large patient pool which are suffering from neurological disorders and high diagnosis & treatment rates of neurological diseases in this region. According to CDC (Centres for Disease Control and Prevention), around 30% population of U.S. suffered from active epilepsy and 0.02% of the population was diagnosed with Parkinson’s disease. In addition, high investment in the development of healthcare infrastructure, availability of large market players and technological advancement are some other factors that bolster the growth of Brain Pacemaker Market in this region.
Asia Pacific is accounted to mention the fastest growth of Brain Pacemaker Market in 2021. Factors such as, well-developed health care infrastructure, high aging population, and rising cases of neurological diseases are influencing the maximum growth of Brain Pacemaker Market in this region.
List of Prominent Players in the Brain Pacemaker Market:
Speak To Analyst @ https://www.vantagemarketresearch.com/brain-pacemaker-market-1312/contact-analyst
January, 2021: Medtronic plc. announced its first enrolment in ADAPT-PD (Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease). This adaptive deep brain stimulation is an investigational feature of the Percept™ PC device and provide therapy to manage symptoms of Parkinson’s disease based on a patient’s clinical state.
June, 2020: Medtronic plc. received Food and Drug Administration (FDA) approval for the Percept™ PC Deep Brain Stimulation (DBS) system. Brain Sense™ technology makes Percept the first and only DBS neuro-stimulation system with the ability to chronically capture and record brain signals while delivering therapy to patients with neurologic disorders associated with Parkinson’s disease, essential tremor, dystonia, epilepsy or obsessive-compulsive disorder (OCD).
Key questions answered in the report:
This market titled “Brain Pacemaker Market” will cover exclusive information in terms of Geographic Segmentation, Regional Analysis, Forecast, and Quantitative Date – Units, Key Market Trends, and various others as mentioned below:
Customization of the Report:
The report can be customized as per client needs or requirements. For any queries, you can contact us on firstname.lastname@example.org or +1 (202) 380-9727. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.
Download Free Sample Report Now @ https://www.vantagemarketresearch.com/brain-pacemaker-market-1312/request-sample
Browse More Related Report:
About Vantage Market Research:
We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.
Follow Us on LinkedIn: https://www.linkedin.com/company/vantage-market-research/
Follow Us on Twitter: https://twitter.com/vantagemarketr
6218 Georgia Avenue NW Ste 1 – 564
Washington DC 20011-5125
United States Tel: +1 202 380 9727
Latest Vantage Market Research Press Releases @ https://www.vantagemarketresearch.com/insight/press-releases
Latest Vantage Market Research Blog @ https://www.vantagemarketresearch.com/insight/blogs